As technology advances, the demand for advanced wearable medical devices has seen a rapid increase in the past five years, including smart prosthetic hands and limbs, multi-monitoring devices for human physiology, and more recently, human performance augmentation technologies. The growth rate of the wearable medical device industry is expected to compound annually at a rate of 16%, and for multi-monitoring devices, 45%. In fact, the medical technology sector is expected to outperform pharmaceuticals by 2018. Founded in 1965, the UNB Institute for Biomedical Engineering is recognized as one of the top five research organizations of its kind in the world.
As the New Brunswick Innovation Research Chair in Medical Devices and Technology, Dr. Scheme’s mandate is to position New Brunswick as a world leader in the discovery, innovation and commercialization of medical devices and technologies. He will lead the growth of New Brunswick’s emerging medical devices industry by making it a destination of choice for new and existing companies, entrepreneurs, and exceptional students. Working with a large internal team, and from other public and private organizations, Dr. Scheme’s focus is to effectively put the results of their collective work into the hands of industry.
Dr. Erik Scheme is a Research Engineer in biological signal processing and control, human-machine interfaces, and product design at the University of New Brunswick’s Institute for Biomedical Engineering. Recipient of the 2013 Governor General’s Gold Medal for Academic Excellence, he has published articles in the Journal of Prosthetics and Orthotics, the Journal of Rehabilitation Research and Development, and others. Dr. Scheme received his PhD in Biomedical Engineering at the University of New Brunswick. His research chair is valued at $1.175 million.